TransCode Therapeutics Inc. (RNAZ:NASDAQ) soared at $0.61, representing a gain of 51.8%. On Wed, Dec 28, 2022, RNAZ:NASDAQ hit a New 2-Week High of $0.61. The stock got featured on our News Catalysts scanner on Wed, Dec 07, 2022 at 05:27 PM in the 'BIOTECH' category. From Wed, Dec 14, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Dec 07, 2022 at $1.17 with a volume of 114M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 218.37%
- Minerva Surgical Inc. (UTRS:NASDAQ), 66.15%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 51.82%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 45.06%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 44.74%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 42.98%
- Nuwellis Inc. (NUWE:NASDAQ), 37.48%
- Argo Blockchain plc (ARBK:NASDAQ), 36.29%
- Unico American Corporation (UNAM:NASDAQ), 35.96%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 33.79%